Plasmatic lipid profile indicators related to insulin resistance;Indicadores do perfil lipídico plasmático relacionados à resistência à insulina

Revista da Associacao Medica Brasileira

Volumn 55, Issue 3, 2009, Pages 342-346

  Vasques, Ana Carolina Junqueira ^a   Rosado, Lina Enriqueta Frandsen Paez de Lima ^b   Rosado, Gilberto Paixão ^b   Ribeiro, Rita de Cassia Lanes ^b   Franceschini, Sylvia do Carmo Castro ^b   Priore, Silvia Eloiza ^b   Geloneze, Bruno ^a   de Oliveira, Dirce Ribeiro ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Universidade Federal de Viçosa   (United Kingdom)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

HOMA; Insulin resistance; Lipoproteins; Triglycerides

Indexed keywords

EID: 69149101311     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302009000300030     Document Type: Article

References (24)

1. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007;375:20-35.
2. Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007;30:2091-7.
3. Geloneze B, Tambascia MA. Avaliação laboratorial e diagnóstico de resistência insulínica. Arq Bras Endocrinol Metabol. 2006;50:208-15.
4. Vasques ACJ, Rosado LEFPL, Alfenas RCG, Geloneze B. Análise crítica do uso dos índices do Homeostasis Model Assessment (HOMA) na avaliação da resistência à insulina e capacidade funcional das células-b pancreáticas. Arq Bras Endocrinol Metabol. 2008;52:32-9.
5. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802-9.
6. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399-404.
7. Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes. 2006;7:260-6.
8. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196:696-703.
9. Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Metabolism. 2007;56:899-904.
10. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005;165:1395-400.
11. Pimenta JR, Zuccherato LW, Debes AA, Maselli L, Soares RP, Moura-Neto RS, et al. Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered. 2006;62:190-5.
12. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Nefrologia. V Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol. 2007;89:e24-e79.
13. Jelliffe DB. Evaluación del estado nutrición de la comunidad. Ginebra: Organización Mundial de La Salud, 1968. p.166.
14. World Health Organization. (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
17. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-43.
18. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-9.
19. Oliveira EP, de Lima MD, de Souza ML. Metabolic syndrome, its pheno-types, and insulin resistance by HOMA-IR. Arq Bras Endocrinol Metabol. 2007;51:1506-15.
20. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801.
21. Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest. 2006;116:1813-22.
22. Zavaroni I, DallAglio E, Alpi O, Bruschi f, Bonora E, pezzarossa A, et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis. 1985;55:259-66.
23. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med. 1992;231:25-30.
24. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem. 2007;53:922-32.